Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Share-based Compensation: 2022-2023

Historic Share-based Compensation for Therapeutics (LENZ) over the last 2 years, with Dec 2023 value amounting to $518,000.

  • Therapeutics' Share-based Compensation fell 85.70% to $518,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $5.7 million, marking a year-over-year decrease of 58.14%. This contributed to the annual value of $6.4 million for FY2024, which is 373.94% up from last year.
  • According to the latest figures from Q4 2023, Therapeutics' Share-based Compensation is $518,000, which was down 76.03% from $2.2 million recorded in Q3 2023.
  • In the past 5 years, Therapeutics' Share-based Compensation registered a high of $3.6 million during Q4 2022, and its lowest value of $142,000 during Q1 2023.
  • Its 2-year average for Share-based Compensation is $2.4 million, with a median of $3.0 million in 2022.
  • Data for Therapeutics' Share-based Compensation shows a maximum YoY plummeted of 95.75% (in 2023) over the last 5 years.
  • Therapeutics' Share-based Compensation (Quarterly) stood at $3.6 million in 2022, then tumbled by 85.70% to $518,000 in 2023.
  • Its Share-based Compensation was $518,000 in Q4 2023, compared to $2.2 million in Q3 2023 and $2.8 million in Q2 2023.